{
  "paper_metadata": {
    "pmid": "9095004",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR Met-30 variant associated with familial amyloidotic polyneuropathy."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.90G>A",
      "protein_notation": "p.Met30Val",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "homozygous familial amyloidotic polyneuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "neuropathy symptoms",
          "evidence_sentence": "The patient presented with neuropathy symptoms at age 45."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 52,
          "age_at_onset": 50,
          "age_at_diagnosis": 51,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "cardiac symptoms",
          "evidence_sentence": "The patient developed cardiac symptoms at age 50."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 40,
          "age_at_onset": 39,
          "age_at_diagnosis": 40,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "no symptoms",
          "evidence_sentence": "The individual remains asymptomatic at age 40."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 45,
          "age_at_onset": 44,
          "age_at_diagnosis": 45,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "neuropathy symptoms",
          "evidence_sentence": "The patient exhibited neuropathy symptoms at age 44."
        }
      ],
      "functional_data": {
        "summary": "The TTR Met-30 variant leads to amyloid deposition.",
        "assays": [
          "T4-binding studies",
          "serum analysis"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study established a transgenic mouse model for TTR Met-30.",
      "key_quotes": [
        "In these mice, human TTR Met-30-derived amyloid deposits were first observed in the esophagus and stomach when the mice were 11 months of age.",
        "Because no significant difference was detected in the onset, progression, and tissue distribution of amyloid deposition between the ttr-/- and ttr+/+ transgenic mice expressing 6.0-hMet 30."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text."
  }
}